The hepatitis C endgame: Science, Policy, Politics

The sense of ‘endgame’ is intensifying as we enter the ‘final phase’ of global targets to eliminate hepatitis C, among other viruses, by 2030. The endgame to eliminate hepatitis C is partly made up in elimination targets and measures of progress. The endgame is also made up in the translations of global biomedical promise into interventions, community actions and policies. In this session, we look critically at the science, policy and politics of the hepatitis C elimination endgame. The presentations consider what the endgame means and how it might be played better, the uneven global progress of efforts to eliminate hepatitis C, the challenges of structural intervention and the dominance of biomedicine, and how progress and success is being evidenced. The session is chaired by Sarah Larney (Canada) and includes presentations by Michel Kazatchkine (Switzerland), Gregory Dore (Australia), Tim Rhodes (UK) and Kari Lancaster (Australia).